Pikralida Sp. z o.o.

Pikralida, a biopharmaceutical startup founded in 2019 in Greater Poland, focuses on developing medicines for unmet medical needs, especially neurological and civilization diseases in the elderly. Its flagship project PKL-021, an MMP (matrix metalloproteinase) inhibitor, successfully completed Phase 1 clinical trials. A team of 20+ specialists offers organic synthesis, pharmaceutical analytics, dosage form development and preclinical/clinical studies.